Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.45 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.43 |
| ▸ | ABCC9 | O60706 | 3/20 | 0.31 |
| ▸ | KCNJ11 | Q14654 | 3/20 | 0.31 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.30 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31571443 | 1.00 | KDM1A (0.45) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL27920144 | 0.93 | KDM1A (0.42) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL27920142 | 0.93 | KDM1A (0.42) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL31571444 | 0.90 | KDM1A (0.46) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL9555964 | 0.88 | KDM1A (0.39) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL9555968 | 0.88 | KDM1A (0.39) | KDM1ARCOR1KCNH2KDM1BABCC9 | |
| SCHEMBL8997270 | 0.88 | HTR2A (0.36) | KDM1ARCOR1ABCC9KCNJ11 | |
| SCHEMBL9556367 | 0.87 | KDM1A (0.40) | KDM1ARCOR1KCNH2KDM1B | |
| SCHEMBL9556374 | 0.87 | KDM1A (0.40) | KDM1ARCOR1KCNH2KDM1B | |
| SCHEMBL10501948 | 0.84 | CYP2C9 (0.31) | KDM1ARCOR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573923-B2 | Liquid crystal compound having 2, 6-difluorophenylether structure, and liquid crystal composition containing the same | DIC CORPORATION (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9573923-B2 | Liquid crystal compound having 2, 6-difluorophenylether structure, and liquid crystal composition containing the same | DIC CORPORATION (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160159765-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYLETHER STRUCTURE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | DIC CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160159765-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYLETHER STRUCTURE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | DIC CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159765-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYLETHER STRUCTURE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | FGFR2, FGFR1, FGF2 | KDM1A 3393/4885RCOR1 4814/4885KCNH2 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.